Last update 01 Nov 2024

Adalimumab biosimilar(Alvotech)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Adalimumab Biosimilar (Alvotech hf), 阿达木单抗生物类似药(Alvotech hf), AVT-02
+ [8]
Target
Mechanism
TNF-α inhibitors(Tumor necrosis factor α inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Polyarticular Juvenile Idiopathic Arthritis
CA
10 Jan 2022
Crohn's disease, active moderate
EU
15 Nov 2021
Crohn's disease, active moderate
IS
15 Nov 2021
Crohn's disease, active moderate
LI
15 Nov 2021
Crohn's disease, active moderate
NO
15 Nov 2021
Crohn's disease, active severe
EU
15 Nov 2021
Crohn's disease, active severe
IS
15 Nov 2021
Crohn's disease, active severe
LI
15 Nov 2021
Crohn's disease, active severe
NO
15 Nov 2021
Non-infectious anterior uveitis
EU
15 Nov 2021
Non-infectious anterior uveitis
IS
15 Nov 2021
Non-infectious anterior uveitis
LI
15 Nov 2021
Non-infectious anterior uveitis
NO
15 Nov 2021
Panuveitis
EU
15 Nov 2021
Panuveitis
IS
15 Nov 2021
Panuveitis
LI
15 Nov 2021
Panuveitis
NO
15 Nov 2021
Uveitis, Intermediate
EU
15 Nov 2021
Uveitis, Intermediate
IS
15 Nov 2021
Uveitis, Intermediate
LI
15 Nov 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoinflammatory diseaseNDA/BLA
US
28 Feb 2022
InflammationPhase 1
AU
20 Mar 2019
InflammationPhase 1
NZ
20 Mar 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
107
gzuluzrmsb(aaditcxzdj) = euhioneako qeuqcbqtux (ggdyroqxhk )
Positive
07 Oct 2022
Phase 3
107
AVT02 with autoinjector (AI)
aqftaubwmc(ygnlzwavyh) = hvwgemxbky vckqhzbnpt (zptqwgtyel )
-
01 Jun 2022
AVT02 with pre-filled syringe (ALVOPAD-PEN)
aqftaubwmc(ygnlzwavyh) = mctjjsybqg vckqhzbnpt (zptqwgtyel )
Phase 3
413
dgkbuljvtd(xsfqdlkbkg) = uvkyjctdmp preneurqov (vksgifryxi )
Similar
01 Nov 2021
dgkbuljvtd(xsfqdlkbkg) = gzfegvlulr preneurqov (vksgifryxi )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free